Advancing Drug Purity: Impurity Standards for Josamycin, Ketamine & Maduramicin from Aquigen Bio

NAVI MUMBAI, India - July 25, 2025 - PRLog -- In the pharmaceutical industry, impurity profiling is a cornerstone of quality assurance. As drug development becomes more complex and regulated, access to precise and reliable impurity standards is vital. At Aquigen Bio, we are proud to support this need through an ever-expanding catalog of impurity reference materials tailored to modern pharmaceutical and bioanalytical research.

Today, we spotlight three critical categories of impurity standards that play a key role in anti-infectives, anesthetics, and veterinary applications: Josamycin Propionate, Ketamine Hydrochloride, and Maduramicin.

Josamycin Propionate Impurity Standards: Enhancing Macrolide Accuracy
Josamycin Propionate is a macrolide antibiotic used to treat respiratory tract infections and skin diseases. Ensuring its safety and efficacy requires identifying and quantifying its possible impurities, including EP-listed ones.

Aquigen Bio offers a focused range of Josamycin Propionate impurity standards, essential for analytical method development and validation:

Josamycin Propionate — The primary macrolide compound supplied in highly pure form.
Josamycin Propionate EP Impurity A — Supports analytical profiling and helps meet pharmacopoeial specifications.

https://aquigenbio.com/products/impurity-standards/ibrutinib/
Josamycin Propionate EP Impurity B — Critical in stability studies and impurity threshold evaluations.
With these impurity standards, pharmaceutical labs can conduct accurate impurity quantification, helping reduce batch failures and maintain consistent product quality.
https://aquigenbio.com/product/ibrutinib/
Ketamine Hydrochloride & Analog Impurities: Ensuring Safety in Anesthetics
Ketamine Hydrochloride is a widely used dissociative anesthetic with emerging roles in treating depression and PTSD. The demand for precise impurity standards around ketamine is increasing, particularly as new analogs and degradation products come under regulatory focus.